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OBJECTIVE — The long-term outcome and functional status of subjects hospitalized for
diabetic foot ulcers have been poorly studied and thus are the topics of this study.
RESEARCH DESIGN AND METHODS — Ninety-four consecutive diabetic subjects
hospitalized for diabetic foot ulcers between January 1998 and December 2000 were prospec-
tivelyfollowedformean  SD79.513.3months.Wecalculatedratesofprimaryhealing,new
ulcers,amputations,mortality,anddisabilityandevaluatedtheglobaltherapeuticsuccess(GTS)
of foot care management as deﬁned by the association of primary healing without recurrence or
disability at the end of follow-up.
RESULTS — Follow-up was successful in 89 of 94 subjects (63 men and 31 women; age
63.7  10.8 years). Of these, 69 (77.5%) experienced primary healing without major amputa-
tion, 39 (43.8%) underwent amputation (24 minor and 15 major), and 46 died (51.7%),
including 23 from cardiovascular events. Forty-two of 69 patients who experienced primary
healing (60.9%) had ulcer recurrence. At the end of the follow-up period, 25 patients (28.1%)
were dependent and 40 subjects (44.9%) had achieved GTS. Multivariate analysis showed the
role of age as an independent predictor of GTS (P  0.05) and of impaired renal function/
albuminuria as independent predictors of healing failure, ﬁrst amputation, and mortality (P 
0.01).
CONCLUSIONS — Despite a satisfactory initial healing rate, the global long-term outcome
of patients hospitalized for diabetic foot ulcers was poor. Nephropathy appears to be an impor-
tant predictor of long-term outcome. Further studies are needed to establish recognized criteria
for therapeutic success going beyond just the evaluation of healing rate in the management of
diabetic foot ulcers.
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D
iabeticfootulcersrepresentamajor
public health concern (1) and are
commonly viewed as a lower-
extremity disease associated with a high
amputation rate (2). They are generally
associated with advanced micro- and
macroangiopathy,resultinginexcessively
high morbidity and mortality (3).
Pathogenic mechanisms and thera-
peutic options for foot ulcers have been
extensivelystudied,leadingtoaninterna-
tional consensus in 1999 (4). However,
most studies have focused on ulcer-
related outcomes over short periods of
time (healing, change in area, or amputa-
tions), rather than evaluation of long-
term patient-related outcomes (5–7).
Recently,Jeffcoateetal.(8)usedtheasso-
ciation of survival, absence of any ampu-
tation, and freedom from ulcers as an
estimate of patient-related outcomes,
showing that ulcer-related outcomes may
extensively underestimate the true mor-
bidity and mortality associated with dia-
beticfootdisease.However,theseauthors
did not evaluate functional outcome, and
their measurements were conﬁned to the
ﬁrst year after initial registration in their
clinic.Theaimofthepresentstudywasto
analyzethelong-termoutcomeofdiabetic
patients after hospitalization for foot ul-
cers using a scale for disability (9) and to
investigate possible prognostic factors.
RESEARCH DESIGN AND
METHODS— From January 1998 to
December 2000, all patients hospitalized
in our department for diabetic foot ulcers
were included in a cohort. Admission for
inpatient treatment was ordered if a limb-
threatening infection and/or nonfavor-
able evolution of the wound despite
standard outpatient care was observed,
according to international recommenda-
tions (4). Limb-threatening infection was
deﬁned by the presence of full-thickness
ulcer, 2 cm of cellulitis with or without
lymphangitis, bone or joint involvement,
or systemic toxicity. Standard outpatient
care included pressure ofﬂoading, treat-
ment of infection including debridement,
local wound care, podiatric care, adapted
footwear when needed, metabolic con-
trol, and treatment of comorbidities and
associatedriskfactorsincludingsmoking,
hypertension,anddyslipidemia.Theevo-
lution of the wound was considered non-
favorable in the case of an aggravation at
two consecutive visits or in the absence of
any improvement after 1 month of care.
During that period of time, 94 patients
were included in the cohort.
Each patient gave oral informed con-
sent, in accordance with the European
directives as edited in 2001 (available
from http://europa.eu/eur-lex/pri/en/oj/
dat/2001/l_121/l_12120010501
en00340044.pdf), which require no
approval from an ethics committee for a
study design as described herein.
Participants were considered to have
type 2 diabetes if they had no history of
ketosis and if they did not commence in-
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the diagnosis or before age 40 years. Oth-
erwise, they were considered to have type
1 diabetes.
Past history of myocardial infarction
was determined using medical records
and/or when an electrocardiographic Q
wave was present. Hypertension was di-
agnosedifoneofthefollowingconditions
was present: systolic blood pressure
130 mmHg, diastolic blood pressure
80 mmHg, or the presence of at least
one antihypertensive medication. Pa-
tients were considered smokers if they
were current smokers or if they stopped
smoking 3 years before admittance.
Peripheralneuropathywasdiagnosed
when two criteria were met among the
following: paresthesias, neuropathic
pain, altered 10-g Semmes-Weinstein
monoﬁlament test, and diminished ankle
reﬂexes. Peripheral arterial disease was
diagnosed in the case of abolition of 2
peripheral pulses and/or 1 signiﬁcant
stenoses as shown by Doppler ultrasound
or by a reduction of lumen diameter
50% or an occlusion of 1 artery as
shown by angiogram.
Arterial stenoses diagnosed by Dopp-
ler ultrasound were deemed signiﬁcant
when occlusions, single or multiple ste-
noses, or diffuse stenotic disease in the
femoropopliteal segments, individually
or collectively, caused signiﬁcant velocity
change and ﬂow disturbance locally and
resulted in loss of reverse ﬂow distally or
in the presence of occlusions of arteries
below the knee. Lesions were classiﬁed as
ischemic wounds when peripheral arte-
rial disease was diagnosed or as nonisch-
emic wounds otherwise.
Wounds were graded using Wagner’s
classiﬁcation (10). The lesions were then
categorizedintotwomainclinicalgroups:
skin ulcers (Wagner 1 and 2) and critical
ulcers, which included both deep tissue
infections and suspected osteomyelitis
(Wagner 3), and gangrenous lesions
(Wagner 4 and 5).
Wedeﬁnedafootinfectionbyclinical
criteria consistent with the International
Working Group guidelines (4) (i.e., the
presence of purulence or 2 other local
signs of inﬂammation). We evaluated pa-
tients with an infection for the extent of
soft tissue involvement and for evidence
of bone involvement. Bone infection was
suspectedinthepresenceofpositivebone
probing(11)andwasconﬁrmedeitherby
magnetic resonance imaging or by a stan-
dard
99mTc-hexamethylpropyleneamine
oxime leukocyte scan.
The biological and bacteriological
data considered were the ﬁrst realized af-
ter admittance. In the presence of clinical
infection, culture specimens were ob-
tained using deep swabbing and/or surgi-
cal debridement.
A1C was measured using high-
performanceliquidchromatographywith
an automated analyzer (Menarini, Rungis
Cedex, France). The instrument was cali-
brated according to Diabetes Control and
Complications Trial standards (reference
range 4.1–5.7%). The urinary albumin
excretion rate was measured by radioim-
munoassayon24-hurinecollections,and
diabetic nephropathy was deﬁned by uri-
naryalbuminexcretionrate30mg/day.
Theserumcreatininelevelwasmeasured,
and creatinine clearance was calculated
according to the Cockroft-Gault formula.
Renal impairment was deﬁned as creati-
nine clearance 60 ml/min.
Follow-up data were obtained during
the month of July 2007 (which was 5.5
years after the last patient’s inclusion)
through a telephone interview of each pa-
tient’s family physician or diabetologist,
using a speciﬁcally designed question-
naire. The clinical outcomes considered
wereprimarywoundhealing,ulcerrecur-
rence, major amputation, death, disabil-
ity, and global therapeutic success (GTS)
for diabetic foot management, deﬁned as
the association of primary healing, ab-
sence of recurrence, and no disability. If
death occurred during the follow-up pe-
riod, GTS was considered if the three cri-
teria were met at the time of death.
Primarywoundhealingwasconsideredto
be achieved when total disappearance of
the initial ulcer was reported without ma-
jor amputation of the limb. Ulcer recur-
rence was reported when the subject
developed a new ulcer after a successful
primaryhealing.Anamputationwascon-
sideredasmajorifitwasperformedabove
themidtarsallevelandasminorotherwise
(4). Cardiovascular death was deﬁned as
death caused by ischemic heart disease,
acutepulmonaryedema,acutecongestive
heart failure, cardiogenic shock, stroke,
or sudden death. Death was considered
wound-relatedwhenitwascausedbyim-
mobilization (pulmonary embolism) or
sepsis due to wound infection or when it
occurred during wound-related events
such as vascular surgery.
Disability was assessed by Katz’s In-
dex of Activities of Daily Living (9). This
index measures performance in six per-
sonal activities of daily living: bathing,
dressing, toileting, transfer, continence,
and feeding. It consists of six items with
binary quotations of 1 or 0 based on the
individual’s ability to perform the corre-
sponding activity without assistance by
another individual. Patients living with a
partner were considered independent if
they were able to perform the activity
when left alone. A subject whose score
was 3 was regarded as very dependent
(12). Hence, in the present study, we de-
ﬁneddisabilityasaKatz’sIndexscore3.
Statistical analysis was performed
using StatView (SAS Institute, Cary,
NC) and StatBox Pro 6.0 (GrimmerSoft,
Issy Les Moulineaux, France). The nor-
mality of the distribution of each quanti-
tative parameter was assessed using the
Kolmogorov-Smirnov test. If normality
was established, results were given as
mean  SD, and comparisons were made
using the Student’s t test for unmatched
series. Otherwise, the results were given
as median (range), and comparisons were
made using the nonparametric Mann-
Whitney U test. Discontinuous parame-
ters were calculated as a frequency and
expressed as percentages. Univariate
analyses between qualitative parameters
were made using the 
2 test with the
Yates’ test. We used logistic regression
analyses to compute the relative risks
(RRs) of an end point associated with dif-
ferent factors. Multivariate analysis to
identify independent predictive factors
was performed using Cox’s logistic re-
gression. The entry criterion was P  0.1,
and the permanence criterion was P 
0.05. Predictive value was expressed as
RR with a 95% CI. Kaplan-Meier curves
were used to compare survival between
twogroups,andsigniﬁcancewasassessed
by log-rank test. For all tests, signiﬁcance
was set at P  0.05.
RESULTS— Follow-up data were ob-
tained in 89 of 94 (95%) patients. The
main characteristics of the patients at in-
clusion are given in Table 1. Mean  SD
follow-up was 79.4  13.3 months
(range 66.1–92.6).
Of the 89 patients, 82 (92.1%) had
sensorimotor diabetic neuropathy and 41
(46.1%) had ischemic wounds; a total of
48 (53.9%) patients were considered
purely neuropathic. Fifteen of the 89 pa-
tients in the cohort (16.9%) underwent
vascular procedures.
Primary healing
Primary healing was achieved in 69 of 89
patients (77.5%) (Table 2). Univariate
predictors of healing failure were smok-
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0.05), popliteal stenosis (3.6 [1.28–
10.14]; P  0.02), and renal impairment
(6.45 [2.17–10.83]; P  0.0001). All 14
patients (100%) with nonischemic
wounds and 55 of 75 patients (73.3%)
with ischemic wounds achieved primary
healing (P  0.06). After factors associ-
ated with healing failure at P  0.1 in
univariateanalysiswereintroducedintoa
multivariate model, renal impairment
(6.21[1.28–31.05];P0.03)andsmok-
ing (6.11 [1.42–26.30]; P  0.02) were
found to be independent predictors of
healing failure.
Ulcer recurrence
Among the 69 patients who achieved pri-
mary healing, 42 (60.9%) developed a
new ulcer during the follow-up period
(Table2).Insulintreatmentbeforeadmis-
sionwastheonlypredictorofulcerrecur-
rence, both in univariate analysis (RR
3.87 [95% CI 1.37–10.98]; P  0.006)
andafteradjustmentforfactorsassociated
at P  0.01 in univariate analysis, i.e.,
ischemia and osteitis (4.61 [1.35–15.79];
P  0.015).
Amputations
Thirty-nine of the 89 patients in the
whole cohort (43.8%) underwent an am-
putation (30 minor and 9 major) (Table
2). Univariate predictors of amputation
were critical ulcers (RR 3.01 [95% CI
1.26–7.21]; P  0.01), ischemic wounds
(6 [1.26–28.69]; P  0.003), suprapop-
liteal stenosis (14.4 [1.73–119.48]; P 
0.01), and popliteal stenosis (4.03 [1.03–
10.12]; P  0.003). In multivariate anal-
ysis, popliteal stenosis was the only
independent predictor of amputation
(3.67 [1.34–10.07]; P  0.01).
Regarding major amputations, past
history of lower limb revascularization
(RR 5.80 [95% CI 1.38–24.40]; P 
0.02), previous amputation (either minor
or major) (5.52 [1.27–24.10]; P  0.02),
and critical ulcers (11.15 [1.33–93.52];
P  0.03) were found to be univariate
predictors, but none of these factors re-
mained as independent predictors in
multivariate analysis.
Even though the rate of amputation
was higher in the group of patients with a
previous history of amputation (15 of 27
patients, 55.6%) compared with those
who did not have a previous history of
amputation (23 of 62 patients, 37.1%),
thedifferencebetweenthesetwogroups
did not reach the level of statistical
signiﬁcance.
Amongthe62patientswithoutprevi-
ous amputation, univariate predictors of
ﬁrst amputation were diabetic nephropa-
thy (RR 5.54 [95% CI 1.59–19.32]; P 
0.008) and ischemic wounds (8.54
[1.03–72.16]; P  0.05). After multivar-
iate analysis, only diabetic nephropathy
remained as an independent predictor of
ﬁrst amputation (6 [1.62–22.21]; P 
0.01).
Disability
Twenty-ﬁve subjects (28.1%) were con-
sidered to have a disability (Katz’s Index
3) at the end of the follow-up period or
at the time of their death (Table 2). Pa-
tients with a disability were older at the
time of entry into the study than those
without (70.1  8.3 vs. 61.5  10.7
years, respectively; P  0.001). Other
univariate associates of disability were re-
nal impairment (RR 3.76 [95% CI 1.26–
11.24]; P  0.01) and history of
amputation (3.02 [1.14–7.99]; P  0.03).
None of these factors remained as indepen-
dent predictors of disability after multivari-
ate analysis.
GTS
GTS was achieved for 40 subjects
(44.9%): 28 (31.5%) who were alive at
the end of the follow-up period and 12
(13.4%) who had died (Table 2). In the
subgroup of 43 patients still alive at the
end of the follow-up period, the GTS rate
was 65.1%. In the subgroup of 46 de-
ceased patients, the GTS rate was 26.1%
(P  0.001).
In univariate analysis, failure to reach
GTS was associated with advanced age
(66.6  9.3 vs. 59.8  11.6 years, GTS
vs.noGTS;P0.01),previoushistoryof
footulcers(RR2.67[95%CI1.03–6.91];
P  0.05), and insulin therapy before ad-
mission (2.63 [1.06–6.53]; P  0.04). In
multivariate analysis, age 70 years was
the only independent predictive factor
that persisted (2.8 [1.01–7.67]; P 
0.05).
Mortality
Forty-six patients (51.7%) died during
the follow-up period, including 23
(25.8%) from a cardiovascular event, 9
(19.6%) from a wound-related event, 7
(15.2%) from malignancies, and 7
(15.2%) from other causes (Table 2). In
univariate analysis, mortality was associ-
ated with advanced age (68  9.1 vs.
57.510.8years,deceasedvs.alive;P
0.001), renal impairment (RR 6.93 [95%
CI 2.67–18.04], P  0.0001), and past
history of amputation (3.08 [1.17–8.59];
P0.03).Whendisability,age,renalim-
pairment, and history of myocardial in-
farction were considered in a multivariate
analysis, only renal impairment (4.57
[1.1–19.4];P0.05)wasidentiﬁedasan
independent predictor of mortality (Fig.
1).
Afterbothunivariateandmultivariate
analyses with the introduction of insulin
therapy, renal impairment, and history of
myocardial infarction into the model, we
found the independent predictive factors
for cardiovascular mortality to be insulin
therapy before admittance (RR 13.14
[95% CI 1.39–124.48]; P  0.05) and
Table 1—Patients’ baseline characteristics
Total
n 89
Male sex 62 (69.7)
Age (years) 63.8  10.8
Diabetes duration (years) 24.0  11.3
Type 1 diabetes 11 (12.4)
Past history of myocardial
infarction
21 (23.6)
Past history of amputation 27 (30.4)
Minor 18 (20.3)
Major 9 (10.1)
BMI (kg/m²) 26.6  4
Ischemic wounds 75 (84.3)
Critical wounds (Wagner 3) 41 (46.1)
A1C (%) 9.2  1.7
Insulin therapy 60 (67.4)
Retinopathy 65 (75.3)
Nephropathy 52 (58.4)
Creatinine clearance (ml/min) 73.3  30
High blood pressure 84 (94.4)
Dyslipidemia 74 (83.1)
Data are mean  SD or n (%).
Table 2—Main outcomes
Total
n 89
Primary healing 69 (77.5)
Recurrent ulceration 42 (60.9)
Amputations 39 (43.8)
Minor 30 (33.7)
Major 9 (10.1)
All-cause mortality 46 (51.7)
Cardiovascular
mortality
23 (25.8)
GTS for diabetic
foot management
40 (44.9)
Data are n (%). Percentage is calculated in propor-
tiontothe69patientswhoreachedprimaryhealing.
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0.01).
CONCLUSIONS — Most previous
studies evaluating diabetic foot ulcer out-
come were short-term studies (5 years)
and were limited to ulcer-related end
points, such as healing and amputations.
Thus, in the present report, we evaluated
long-term outcome (6.5 years), including
disability as an end point in a consecutive
series of patients hospitalized at a single
specialized center for foot ulcers. Predic-
torsoflong-termoutcomewereevaluated
further.
The primary healing rate was 77.5%,
but the years after the initial event were
marked by high rates of ulcer recurrence
(60.9%)andamputations(43.8%).Atthe
end of the follow-up period or at the time
of their death, 28.1% of the patients were
considered to have a disability leading to
dependency, which is one of the essential
criteria used to evaluate functional status
(13).Toourknowledge,nodataconcern-
ing prospective evaluation of disability or
dependency in diabetic subjects with foot
ulcers are available nor has it ever been
considered as a therapeutic criterion in
any previous study. Even though it was
not speciﬁcally designed for diabetic sub-
jects with foot ulcers, we chose Katz’s In-
dex to evaluate disability for several
reasons: 1) it is easy to use in routine clin-
ical practice, 2) the French version has
been validated, and 3) it is widely used in
the literature (12).
Dependence is plurifactorial, and one
of today’s crucial issues is the identiﬁca-
tionofeasilymeasurablepredictivemark-
ers to undertake effective interventions
for its prevention. In our study as well as
in the literature, disability was associated
with aging (13,14). Thus, even though
the primary healing rate observed in our
series might be considered satisfactory
and is in agreement with those of pub-
lished prospective studies with a similar
follow-up duration (5,6,15), GTS for foot
care, as deﬁned by healing and absence of
recurrence and disability, occurred in
50% of the patients (44.9%). The deﬁ-
nition we used for GTS in the present
study was based on a pragmatic basis be-
causewewantedittobesimpleenoughto
be used in everyday clinical practice, but
other deﬁnitions, including more criteria,
could have been used.
Vital status was not included as a suc-
cess criterion for foot-ulcer management
in the present study because in this pop-
ulation of diabetic patients, a number of
deaths were unrelated to diabetic foot
care. For example, only 9 of 46 deaths
were directly related to a foot ulcer com-
plication, whereas 7 deaths were related
to malignancies. However, at the end of
the follow-up period, 46 patients had
died, with half of these deaths being due
to a cardiovascular event. Thus, as few as
28 patients (31.5%) were both alive and
considered to have achieved GTS at the
end of the study.
Ulcer recurrence in the present study
is also in agreement with the current lit-
erature (5,15), even though Faglia et al.
(6) reported a much lower value
(12.75%). These authors explained their
particularlygoodresultsasresultingfrom
thefactsthatalloftheirsubjectshadther-
apeutic shoes with an adapted sole and
that their families were educated on foot
care. Of course, all of our subjects were
also directed to wear adapted shoes and
soles and received education regarding
foot care. However, patients in France are
somewhat reluctant to buy devices that
arenotcoveredbythesocialsecurity,asis
the case for therapeutic shoes and soles,
thuslimitingtheiruse.Thiscouldexplain
the difference in rate of ulcer recurrence
between the study of Faglia et al. and
ours.
Similarly, Moulik et al. (7) reported a
limited rate (19%) of amputations for all
levels after 5 years, contrasting with our
amputation rate of 43.8%, which is nev-
ertheless similar to that of other studies
(5,6,15). The lower amputation rate in
thatlatterstudycouldbeexplainedbythe
fact that Moulik et al. included only pa-
tients with new ulcerations.
Diabetic nephropathy appears to be
an important marker of long-term prog-
nosis, with impaired renal function being
an independent predictor of healing fail-
ure, of all-cause mortality, and of cardio-
vascular death and with albuminuria
being associated with amputations. This
latter point is in agreement with a previ-
ous study by Apelqvist and Agardh (16).
These results conﬁrm the importance of
diabetic nephropathy as a marker of ex-
tended angiopathy in patients with dia-
betic foot ulcers.
Ischemia, as deﬁned in the present
study,wasaunivariateassociateofampu-
tation but was not found to be an inde-
pendent predictive factor after correction
for confounding factors. However, other
markers of macroangiopathy were associ-
ated with long-term outcomes, with pop-
litealstenosisasanindependentpredictor
of amputation, conﬁrming that vascular
involvementindiabeticpatientswithfoot
ulcers is particularly important (17).
Thus, our results do not deny the crucial
role of macroangiopathy in the long-term
global prognosis of these subjects (7).
Insulin therapy before admittance
alsoappearsasacentralmarker,asitisan
independent predictive factor of ulcer re-
currence and cardiovascular mortality.
Insulin is generally needed after a long
diabetes duration associated with poor
glycemic control, with both being major
risk factors for micro- and macroangio-
pathic complications (18). Insulin must
thus be considered more as a marker of
the severity of the disease rather than a
risk factor per se.
One of the limitations of our study is
that data were collected via a telephone
interview and not face to face. However,
we do not feel that this limits the validity
or importance of these results.
Figure 1—Kaplan-Meier survival curves comparing survival rate in patients without (b) or with
(a) impaired renal function.
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satisfactory initial healing rate, the global
long-term outcome of patients hospital-
ized for diabetic foot ulcers was poor.
These observations conﬁrm the need to
establish recognized criteria, going be-
yond just healing rate, for the long-term
evaluation of diabetic foot ulcers. Multi-
center trials are needed in this respect.
Our results also stress the importance of
impaired renal function as a predictor of
diabetic foot ulcer outcome and the need
topayparticularattentiontopatientswith
this condition.
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